Medicofarma Biotech (WAR:MDB) FCF Margin % : 34.98% (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Medicofarma Biotech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medicofarma Biotech's Free Cash Flow for the three months ended in Mar. 2024 was zł0.31 Mil. Medicofarma Biotech's Revenue for the three months ended in Mar. 2024 was zł0.87 Mil. Therefore, Medicofarma Biotech's FCF Margin % for the quarter that ended in Mar. 2024 was 34.98%.

As of today, Medicofarma Biotech's current FCF Yield % is 0.48%.

The historical rank and industry rank for Medicofarma Biotech's FCF Margin % or its related term are showing as below:

WAR:MDB' s FCF Margin % Range Over the Past 10 Years
Min: -14.47 Med: -0.7 Max: 20.16
Current: 20.16

During the past 13 years, the highest FCF Margin % of Medicofarma Biotech was 20.16%. The lowest was -14.47%. And the median was -0.70%.

WAR:MDB's FCF Margin % is ranked better than
90.23% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 0.085 vs WAR:MDB: 20.16

Medicofarma Biotech FCF Margin % Historical Data

The historical data trend for Medicofarma Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicofarma Biotech FCF Margin % Chart

Medicofarma Biotech Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-0.34

-11.96

-8.55

-14.47

-5.83

Medicofarma Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-96.48	-420.00	22.86	-23.45	34.98

Competitive Comparison of Medicofarma Biotech's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Medicofarma Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicofarma Biotech's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicofarma Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Medicofarma Biotech's FCF Margin % falls into.

Medicofarma Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Medicofarma Biotech's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-0.248	/	4.252
	=	-5.83 %

Medicofarma Biotech's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0.305	/	0.872
	=	34.98 %

Medicofarma Biotech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Medicofarma Biotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicofarma Biotech (WAR:MDB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicofarma Biotech SA (WAR:MDB) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Soko?owska 9 lok. U19, Warsaw, POL, 01-142

Website

https://www.medicofarma.pl

Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.